Fastbase Inc (OTC:FBSE) Stock, Quote.Headers.trade-ideas

Fastbase Inc

Universal New Energy Holding Group Inc

<ul>
<li>Rezolve Ai supported by Tether to make cryptocurrency mainstream for everyday purchases</li>
<li>Rezolve Ai to address the $600 billion+ global burden of merchant payment processing fees annually</li>
<li>Rezolve Ai plans to set a new global standard for retail payments through innovation, accessibility, and sustainability &nbsp;</li>
</ul>
LONDON, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>), a global leader in AI-powered commerce solutions, is announcing a <a href="https://www.globenewswire.com/Tracker?data=OXs636_65PKU-ZEPjZweo3fVBAb7Jx2cEnv4rwa9z0gH5ujqRs7pRTblgRgghfZb0Su4J9SnpgseEEMd2MV6B0dBFE6dAP0DKUWDkPopn9_UhU5LYWsGl0IhJ07uRCwLBomwYqYHYZEQHknWz0k-W26QL-bZmFS_JX-wseQH7DY=">groundbreaking new product designed with support from Tether</a>, the largest company in the digital asset industry, to revolutionize retail payments. Rezolve Ai will integrate WDK (Wallet Development Kit) by Tether, an open-source crypto wallet library, into its Brain Checkout platform with the aim to make cryptocurrency a mainstream payment method for everyday purchases, eliminating burdensome merchant fees, and creating a seamless cryptocurrency payment system for consumers and retailers alike. The integration will allow users to purchase groceries, meals, and transport with a single tap.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

RZLV

Rezolve Ai Announces A New Product Designed With Support From Tether To Revolutionize Retail Payments. Rezolve Ai Will Integrate WDK By Tether, Into Its Brain Checkout Platform With The Aim To Make Cryptocurrency A Mainstream Payment Method For Everyday Purchases, Eliminating Burdensome Merchant Fees, And Creating A Seamless Cryptocurrency Payment System For Consumers And Retailers Alike

Stifel analyst Brad Reback maintains Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) with a Buy and raises the price target from $20 to $22.

Price Target

Analyst Ratings

BASE

Stifel Maintains Buy on Couchbase, Raises Price Target to $22

OTLK

Outlook Therapeutics Announces National Institute For Health And Care Excellence Has Recommended LYTENAVA As An Option For Treatment Of Wet AMD

Biotech

General

Alterity Therapeutics Limited - American Depositary Shares

ATHE

Alterity Therapeutics Completes Final Patient Visit In ATH434 Phase 2 Trial For Early-Stage Multiple System Atrophy, Topline Data Expected Early 2025

Stifel analyst Benjamin Nolan maintains Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) with a Buy and raises the price target from $204 to $237.

Stifel Maintains Buy on Cheniere Energy, Raises Price Target to $237

SPAI

Safe Pro AI Reaches Milestone In Ukraine, Detecting Over 16,500 Explosive Items With AI-Powered SpotlightAI To Aid Demining And Infrastructure Restoration Efforts

Ashford Hospitality Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) ("Ashford Trust" or the "Company") announced today that it has signed a definitive agreement to sell the 315-room Courtyard Boston Downtown located in Boston, Massachusetts for $123.0 million ($390,500 per key). The sale is expected to be completed in January 2025 and is subject to normal closing conditions. The Company provides no assurances that the sale will be completed on these terms or at all.
When adjusted for the Company's anticipated capital expenditures, the sale price represents a 5.9% capitalization rate on net operating income for the trailing twelve months ended September 30, 2024, or 14.3x Hotel EBITDA for the same time period. Excluding the anticipated capital spend, the sale price represents a 6.9% capitalization rate on net operating income for the trailing twelve months ended September 30, 2024, or 12.3x Hotel EBITDA for the same time period.

Asset Sales

Ashford Hospitality Trust Announces Agreement To Sell The Courtyard Boston Downtown, Located In Boston, Massachusetts For $123M

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Wednesday.
Shares of Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) fell sharply in today's pre-market trading <a href="https://www.benzinga.com/quote/FL/earnings">following third-quarter results</a>.
Foot Locker reported quarterly earnings of 33 cents per share which missed the analyst consensus estimate of 41 cents per share. The company reported quarterly sales of $1.96 billion which missed the analyst consensus estimate of $2.01 billion.
Foot Locker shares dipped 14% to $20.80 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>ZJK Industrial Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) shares fell 13.4% to $14.95 in pre-market trading. ZJK Industrial shares jumped 172% on Tuesday after the company announced it received a request to produce samples for one of NVIDIA&#8217;s upcoming liquid cooling manifold projects.</li>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) fell 12.7% to $12.36 in pre-market trading. Intuitive Machines priced its upsized $110.0 million offering of shares of its Class A common stock and concurrent private placement.</li>
<li>Couchbase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) shares dipped 11% to $18.80 in pre-market trading after the company issued fourth-quarter revenue guidance below estimates.</li>
<li>Gaotu Techedu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) declined 9.4% to $2.70 in pre-market trading following third-quarter results.</li>
<li>GXO Logistics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXO#NYSE">GXO</a>) shares fell 7.6% to $54.50 in pre-market trading. GXO Logistics said CEO Malcolm Wilson has informed board that he plans to retire in 2025.</li>
<li>Crescent Energy Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NASDAQ">CRGY</a>) fell 5.4% to $14.32 in today's pre-market trading. Crescent Energy Company priced its upsized public offering of 21.5 million Class A common shares at $14/share.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>

Pre-Market Outlook

Movers

Trading Ideas

CRGY

GSX Techedu Inc. American Depositary Shares

GOTU

LUNR

Foot Locker Posts Downbeat Results, Joins Couchbase And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">239.75</td>
<td align="right">2.95</td>
<td align="right">1.24</td>
<td>26.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">224.70</td>
<td align="right">0.63</td>
<td align="right">0.28</td>
<td>2.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">100.12</td>
<td align="right">0.11</td>
<td align="right">0.10</td>
<td>750</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">94.3502</td>
<td align="right">-0.16</td>
<td align="right">-0.17</td>
<td>8.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">43.9900</td>
<td align="right">-0.07</td>
<td align="right">-0.16</td>
<td>1.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">82.6000</td>
<td align="right">-0.09</td>
<td align="right">-0.11</td>
<td>246</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.3999</td>
<td align="right">-0.05</td>
<td align="right">-0.10</td>
<td>133.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">146.7000</td>
<td align="right">-0.12</td>
<td align="right">-0.09</td>
<td>4.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">141.9400</td>
<td align="right">-0.09</td>
<td align="right">-0.07</td>
<td>3.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">94.3900</td>
<td align="right">-0.03</td>
<td align="right">-0.04</td>
<td>319</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For December 4, 2024

FRSX

Foresight Signs Cooperation Agreement With 7meerkat And KONEC To Develop And Commercialize Parking Management Solutions

HII To Acquire South Carolina-Based W International Assets And Workforce, Expanding Shipbuilding Capacity For U.S. Navy Submarines And Aircraft Carriers; Financial Terms Not Disclosed

Mitsubishi UFJ Financial Group (<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4317033-1&amp;h=1837255568&amp;u=https%3A%2F%2Fwww.mufgamericas.com%2F&amp;a=MUFG">MUFG</a>), a global leader in financial services, and asset management firm DWS Group (DWS) have launched a strategic venture designed to enhance their respective capabilities in underwriting and distributing infrastructure and alternative credit investments.
&nbsp;
The parties are initially targeting $1 billion of infrastructure and project finance transaction volume per year. DWS' U.S. Infrastructure Debt Platform, managing $4.7 billion of committed capital across funds and CLOs, has been at the forefront of infrastructure financing having made more than 275 investments across infrastructure sub-sectors since 2014. The collaboration marks a significant milestone in DWS' continued expansion into the infrastructure and alternative credit space.&nbsp; MUFG has ranked #1 in industry league tables for Project Finance loan origination in the Americas for more than a decade, and currently agents more than 300 credit facilities for infrastructure assets in the power, energy, digital, and transportation sectors.&nbsp;

MUFG

MUFG and DWS Group Launches A Strategic Venture Designed To Enhance Their Respective Capabilities In Underwriting And Distributing Infrastructure And Alternative Credit Investments.

Morgan Stanley analyst Sanjit Singh maintains Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) with a Equal-Weight and lowers the price target from $27 to $25.

Morgan Stanley Maintains Equal-Weight on Couchbase, Lowers Price Target to $25

Morgan Stanley analyst Simeon Gutman maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Overweight and raises the price target from $97 to $106.

OKTA

Morgan Stanley Maintains Overweight on Okta, Raises Price Target to $106

SLDB

Solid Biosciences Announces Collaboration With Mayo Clinic's Genetic Cardiology Disease Laboratory, Will Receive Exclusive Worldwide Licenses To AAV-Based Suppression-Replacement Gene Therapy Platform And Multiple Cardiac Gene Therapy Programs Developed By Mayo Clinic's Windland Smith Rice Sudden Death Genomics Lab

Fiscal 2025 Outlook As previously announced, the Company reaffirmed its outlook provided in its September 19, 2024 press release. The Company continues to expect the following for fiscal 2025:&nbsp;
<ul>
<li>Total revenue of $3.4 billion to $3.5 billion</li>
<li>Two new Cracker Barrel stores and 3 to 4 new Maple Street Biscuit Company units</li>
<li>Commodity inflation of 2% to 3% compared to the prior year</li>
<li>Hourly wage inflation of 3% to 4% compared to the prior year</li>
<li>Adjusted EBITDA1 of $200 million to $215 million2</li>
<li>Capital expenditures of $160 million to $180 million</li>
</ul>
The Company reminds investors that its outlook reflects a number of assumptions, many of which are outside the Company's control. &nbsp;In particular, uncertainties created by macroeconomic conditions, such as ongoing inflation, low consumer confidence and high interest rates may adversely affect consumer behavior and cause actual results to differ materially from those expected.
1&nbsp;Adjusted net income, adjusted EBITDA and adjusted earnings per diluted share are non-GAAP financial measures. For definitions of these non-GAAP measures and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures, please refer to the Reconciliation of GAAP-Basis Operating Results to Non-GAAP Operating Results section of this release.&nbsp;
2 The Company has determined to provide guidance focused on adjusted EBITDA because the Company believes it will be more useful to investors to evaluate the Company's performance prior to the impact of depreciation (given the expected increase in investments and the resulting higher expected depreciation expense), taxes, closure and impairment charges, and other items that management believes are not reflective of the Company's current operations. The Company is not able to reconcile the forward-looking estimate of adjusted EBITDA set forth above to a forward-looking estimate of net income, the most directly comparable estimated measure calculated in accordance with GAAP, without unreasonable efforts because the Company is unable to predict, forecast or determine the probable significance of certain items impacting these estimates, including interest expense, taxes, closure and impairment charges and share-based compensation, with a reasonable degree of accuracy. Accordingly, the most directly comparable forward-looking GAAP estimate is not provided.

Guidance

CBRL

Cracker Barrel Old Country Store Sees FY25 Revenue $3.4B-$3.5B Vs $3.45B Est.

Morgan Stanley analyst Keith Weiss maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Overweight and raises the price target from $330 to $405.

Morgan Stanley Maintains Overweight on Salesforce, Raises Price Target to $405

Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) shares are trading higher premarket on Wednesday. The company disclosed a multi-year Strategic Collaboration Agreement with Amazon Web Services (AWS) to accelerate AI adoption and enable business leaders across various functions <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42302829/genpact-signs-strategic-collaboration-agreement-with-aws-to-accelerate-ai-adoption" rel="noreferrer noopener">to leverage its transformative potential</a>.
Genpact and AWS are simplifying access to advanced data and AI technologies, empowering decision-makers such as CFOs, COOs, procurement, and operations leaders to foster innovation within their organizations.
This collaboration highlights the combined strengths of Genpact and AWS in delivering flexibility and driving greater business value for customers across various industries.
Murat Aksu, Global Leader for Partnerships, Genpact, said,&nbsp;&#8220;This Strategic Collaboration Agreement will break down traditional barriers to AI adoption, making it accessible to business leaders beyond the CIO&#8217;s office, and help our clients accelerate value through AI-driven insights and solutions.&#8221;
Bob Guilmette, Chief Information Officer, Revol One Financial commented,&nbsp;&#8220;With AWS and Genpact&#8217;s advanced technology expertise, we are streamlining operations, accelerating product launches, and enhancing digital customer experiences, positioning ourselves for sustainable growth and a competitive edge over legacy insurers.&#8221;
Last month, Genpact disclosed the extension of its<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42110009/genpact-announces-renewed-partnership-with-ferring-pharmaceuticals" rel="noreferrer noopener"> partnership with </a><a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42110009/genpact-announces-renewed-partnership-with-ferring-pharmaceuticals" rel="noreferrer noopener">Ferring Pharmaceuticals</a>.
The renewed multi-year agreement will advance the transformation of Ferring&#8217;s finance, accounting, and procurement operations through the use of AI and other advanced technologies.
Investors can gain exposure to Genpact via Innovator IBD Breakout Opportunities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOUT#NYSE">BOUT</a>) and Elevation Series Trust SRH U.S. Quality ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRHQ#NYSE">SRHQ</a>).
Price Action: G shares are up 2.96% at $47.00 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42310228" target="_blank" rel="noreferrer noopener">If You Invested $1000 In Bitcoin When Nvidia&#8217;s Jensen Huang Said Crypto Is &#8216;Going To Be Here For A Long Time,&#8217; Here&#8217;s How Much You&#8217;d Have Now</a></li>
</ul>
Photo by Sundry Photography via Shutterstock.

Equities

Large Cap

Contracts

AMZN

BOUT

Elevation Series Trust SRH U.S. Quality ETF

SRHQ

Genpact Teams Up With Amazon Web Services To Accelerate AI Adoption Across Industries

Cracker Barrel Old (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.41 by 9.76 percent. This is a 11.76 percent decrease over earnings of $0.51 per share from the same period last year. The company reported quarterly sales of $845.09 million which beat the analyst consensus estimate of $836.96 million by 0.97 percent. This is a 2.58 percent increase over sales of $823.84 million the same period last year.

Earnings

Exclusives

Cracker Barrel Old Q1 Adj $0.45 Beats $0.41 Estimate, Sales $845.09M Beat $836.96M Estimate

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) is &#8220;<a href="https://www.benzinga.com/quote/NVTS/analyst-ratings">losing a lot of money.&#8221;</a>
On Tuesday, Navitas Semiconductor announced that Dr. Ranbir Singh, formerly executive vice president at Navitas and the founder and CEO of GeneSiC Semiconductor, has been appointed to the company's board of directors.
Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) is a &#8220;quandary. I've got to tell you, I expected sales to be better,&#8221; Cramer said. &#8220;I do prefer Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)."
On Nov. 15, the FDA accepted for review the resubmission of the supplemental biologics license application (sBLA) for Regeneron Pharmaceuticals and Sanofi SA's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) Dupixent (dupilumab) for patients ages 12 years and older with chronic spontaneous urticaria (CSU) whose disease is not adequately controlled with H1 antihistamine treatment. Wolfe Research analyst Alexandria Hammond initiated coverage on Regeneron Pharmaceuticals with an Outperform rating and announced a price <a href="https://www.benzinga.com/general/biotech/24/11/42008174/fda-to-revisit-regeneron-sanofis-dupixent-for-rare-skin-disease">target of $1150</a>.
Cramer said LandBridge Company LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LB#NYSE">LB</a>) is a &#8220;winner.&#8221; He recommended holding on to the stock.
On Nov. 7, LandBridge reported quarterly sales of $28.487 million, which missed the analyst consensus estimate of $33.323 million. On Dec. 4, Piper Sandler analyst Mark Lear maintained LandBridge with a Neutral rating and raised the price target from $39 to $79.
Price Action:
<ul>
<li>Navitas Semiconductor shares gained 4% to settle at $3.14 on Tuesday.</li>
<li>Regeneron Pharmaceuticals shares fell 1.7% to close at $749.57.</li>
<li>LandBridge shares gained 2.8% to close at $74.84 on Tuesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>
Photo: Shutterstock

Comments

Fastbase Inc

Fastbase Inc (FBSE) Forecast

Fastbase Inc (OTC:FBSE) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga